Cite
HARVARD Citation
Jhaveri, K. et al. (n.d.). Matching adjusted indirect comparison of PFS & OS comparing ribociclib + letrozole vs palbociclib + letrozole as first-line treatment of HR+/HER2− ABC: Analysis based on updated PFS & final OS results of MONALEESA-2 & PALOMA-2. European journal of cancer. pp. S2-S3. [Online].